Watch This Before You Take Ozempic (alarming new research)
Get the full length version of this episode as a podcast.
This episode will make a great companion for a long drive.
The BDNF Protocol Guide
An essential checklist for cognitive longevity — filled with specific exercise, heat stress, and omega-3 protocols for boosting BDNF. Enter your email, and we'll deliver it straight to your inbox.
Weight-loss medications like Ozempic have gained immense popularity for their rapid results, but at what hidden cost? In this clip, metabolic scientist Dr. Ben Bikman examines the lesser-known mechanisms and risks associated with high-dose GLP-1 agonists, including muscle catabolism, nutrient malabsorption, and alarming increases in depression and anxiety. Dr. Bikman advocates for a cautious, low-dose strategy to leverage these powerful drugs, not merely as shortcuts to weight loss, but as carefully timed tools for improving metabolic health and appetite control.
In this video, Dr. Ben Bikman discusses:
- 00:00 - Are drugs like Ozempic a shortcut or solution for obesity?
- 06:39 - Are current GLP-1 agonist doses too high?
- 07:28 - Microdosing GLP-1 drugs—a solution for carb cravings?
- 13:27 - Do these medications cause muscle loss—or is it poor nutrition
- 15:56 - Do GLP-1 agonist benefits extend beyond weight loss?
- 18:07 - Could these treatments actually promote longevity?
- 23:28 - The dark side of GLP-1 drugs—can they trigger depression?
Member only extras:
Learn more about the advantages of a premium membership by clicking below.
Hear new content from Rhonda on The Aliquot, our member's only podcast
Listen in on our regularly curated interview segments called "Aliquots" released every week on our premium podcast The Aliquot. Aliquots come in two flavors: features and mashups.
- Hours of deep dive on topics like fasting, sauna, child development surfaced from our enormous collection of members-only Q&A episodes.
- Important conversational highlights from our interviews with extra commentary and value. Short but salient.
Weight loss News
- GLP-1 receptor agonist weight-loss drugs such as semaglutide may protect the cardiovascular system independent of weight loss.
- Long-term exposure to bright, artificial night light linked to increased risk of overweight and obesity in schoolchildren.
- Single course oral fecal microbiota transplant in adolescents with obesity linked to lower body fat and metabolic risk four years later.
- Inadequate vitamin C levels may limit fat burning during exercise.
- Time-restricted eating helps lose weight without compromising sleep, mood, or quality of life, regardless of when the eating window occurs.
